MedPath

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

Phase 1
Recruiting
Conditions
Influenza
COVID-19 (Coronavirus Disease 2019)
Interventions
Biological: Investigational COVID-19 Vaccine
Combination Product: Investigational Influenza and COVID-19 Combination Vaccine
Biological: Licensed COVID-19 Vaccine
Biological: Licensed Influenza Vaccine 3
Biological: Licensed Influenza Vaccine 1
Biological: Licensed Influenza Vaccine 2
Biological: Investigational Influenza Vaccine
Registration Number
NCT06821061
Lead Sponsor
BioNTech SE
Brief Summary

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.

This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2645
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm AInvestigational COVID-19 VaccineLow Dose COVID-19 Vaccine (1a)
Arm DInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 1)
Arm EInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2)
Arm HLicensed COVID-19 VaccineLicensed COVID-19 Vaccine
Arm EEInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3)
Arm GGLicensed Influenza Vaccine 3Licensed Influenza Vaccine (3)
Arm BInvestigational COVID-19 VaccineLow Dose COVID-19 Vaccine ( 1b)
Arm ILicensed Influenza Vaccine 1Licensed Influenza Vaccine (1)
Arm JInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5)
Arm CInvestigational COVID-19 VaccineLow Dose COVID-19 Vaccine ( 1c)
Arm FInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3)
Arm KInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6)
Arm LInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7)
Arm AAInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 6)
Arm CCInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7)
Arm FFLicensed COVID-19 VaccineLicensed COVID-19 Vaccine
Arm GInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4)
Arm MLicensed COVID-19 VaccineLicensed COVID-19 Vaccine
Arm NLicensed Influenza Vaccine 2Licensed Influenza Vaccine (2)
Arm DDInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2)
Arm HHLicensed Influenza Vaccine 2Licensed Influenza Vaccine (2)
Arm BBInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4)
Arm IIInvestigational COVID-19 VaccineLow Dose COVID-19 Vaccine ( 1b)
Arm JJInvestigational COVID-19 VaccineLow Dose COVID-19 Vaccine ( 1c)
Arm KKInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 4)
Arm LLInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 7)
Arm MMInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (Medium Dose Combination 2)
Arm NNInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 3)
Arm OOInvestigational Influenza and COVID-19 Combination VaccineInvestigational Influenza and COVID-19 Combination Vaccine (High Dose Combination 5)
Arm PPInvestigational Influenza VaccineMedium Dose Investigational Influenza Vaccine (1)
Arm QQInvestigational Influenza VaccineHigh Dose Investigational Influenza Vaccine (2)
Arm RRLicensed COVID-19 VaccineLicensed COVID-19 Vaccine
Arm SSLicensed Influenza Vaccine 3Licensed Influenza Vaccine (3)
Primary Outcome Measures
NameTimeMethod
Percentage of participants reporting prompted systemic events within 7 days following investigational product administrationDay 7
Percentage of participants reporting prompted local reactions within 7 days following investigational product administrationDay 7
Percentage of participants reporting adverse events (AEs) through 1 month following investigational product administration1 month
Percentage of participants reporting serious adverse events (SAEs) through 6 months following investigational product administration6 months
Secondary Outcome Measures
NameTimeMethod
GMTs before and through 1 month following investigational product administrationBefore vaccination through to 1 month after vaccination

Trial Locations

Locations (29)

Upstate Global Health Institute

🇺🇸

East Syracuse, New York, United States

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

AMR Clinical

🇺🇸

Knoxville, Tennessee, United States

Diablo Clinical Research, Inc.

🇺🇸

Walnut Creek, California, United States

DM Clinical Research - Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

DM Clinical Research- Cyfair

🇺🇸

Houston, Texas, United States

SMS Clinical Research

🇺🇸

Mesquite, Texas, United States

Clinical Research Consulting

🇺🇸

Milford, Connecticut, United States

Clinical Research Professionals

🇺🇸

Chesterfield, Missouri, United States

Clinical Research Associates Inc

🇺🇸

Nashville, Tennessee, United States

Kaiser Permanente Washington Health Research Institute (KPWHRI)

🇺🇸

Seattle, Washington, United States

Alliance for Multispecialty Research, LLC

🇺🇸

Coral Gables, Florida, United States

Palm Springs Community Health Center

🇺🇸

Miami Lakes, Florida, United States

J. Lewis Research, Inc. / Foothill Family Clinic South

🇺🇸

Salt Lake City, Utah, United States

Anaheim Clinical Trials, LLC

🇺🇸

Anaheim, California, United States

Orange County Research Center

🇺🇸

Lake Forest, California, United States

Artemis Institute for Clinical Research

🇺🇸

San Diego, California, United States

Miami Dade Medical Research Institute, LLC

🇺🇸

Miami, Florida, United States

East-West Medical Research Institute

🇺🇸

Honolulu, Hawaii, United States

Las Vegas Clinical Trials

🇺🇸

North Las Vegas, Nevada, United States

Coastal Carolina Research Center

🇺🇸

North Charleston, South Carolina, United States

Dynamed Clinical Research, LP d/b/a DM Clinical Research

🇺🇸

Tomball, Texas, United States

Indago Research & Health Center, Inc

🇺🇸

Hialeah, Florida, United States

Clinical Research Atlanta

🇺🇸

Stockbridge, Georgia, United States

Trial Management Associates - Wilmington - Floral Parkway

🇺🇸

Wilmington, North Carolina, United States

Centricity Research Columbus Ohio Multispecialty

🇺🇸

Columbus, Ohio, United States

Headlands Horizons, LLC dba Headlands Research-Brownsville

🇺🇸

Brownsville, Texas, United States

J. Lewis Research, Inc. / Foothill Family Clinic

🇺🇸

Salt Lake City, Utah, United States

Charlottesville Medical Research

🇺🇸

Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath